General practice guidelines support the general practitioners' role to offer CRC screening.
2
Conclusion: The CRC method resulted in a smaller population estimate than expected.
3
The associated chronic inflammatory process associated increases the risk of developing CRC.
4
However, current evidence on smoking in association with CRC prognosis is limited.
5
However, all evidence indicates that increased COX2 activity promotes progression of CRC.
1
Adhesions, hernias, and largebowelcancer are the most common causes of obstruction, as well as of bowel ischemia, necrosis, and perforation.
2
There is clear evidence available which, if applied in a constructive manner could reduce morbidity and mortality, for example, in pulmonary and largebowelcancer.
3
No excess of any alimentary tract cancer was found and the population showed a significant deficit of largebowelcancer mortality (SMR 54).
1
These data indicate that mucinous carcinomaofthelargebowel could represent a histological subset separate from other histotypes.
1
In the elevation of CEA suggests tumor recurrence with a high degree of probability in patients with past history of cancerofthelargebowel.
Uso de colorectal carcinoma em inglês
1
Methodology: Thirteen patients with colorectalcarcinoma metastases to multiple organs were enrolled.
2
Primary prevention of colorectalcarcinoma aims at interruption of the adenoma-carcinoma sequence.
3
One of the best examples being tumor-bud scoring in colorectalcarcinoma.
4
Metastasis is the manifestation most directly affecting survival for patients with colorectalcarcinoma.
5
The mechanisms involved in colorectalcarcinoma with liver metastasis are not well known.
6
DPEP1 is highly expressed in the colorectalcarcinoma tissues and colon cancer cells.
7
Objectives: Surgical excision is the standard strategy for managing liver metastases from colorectalcarcinoma.
8
One partial response was noted in a patient with colorectalcarcinoma refractory to fluoropyrimidines.
9
Metastatic recurrence is the leading cause of cancer-related deaths in patients with colorectalcarcinoma.
10
There is virtually no curative nonsurgical therapy for colorectalcarcinoma.
11
As a control group, 15 patients with colorectalcarcinoma without liver diseases were also selected.
12
Liver metastasis is a common consequence of colorectalcarcinoma.
13
We did not find mutations in another five colorectalcarcinoma and five pancreatic cancer samples.
14
Patients with incurable breast or colorectalcarcinoma had to have good performance status and organ function.
15
Background: Surgery is a safe and effective treatment for patients with lung metastases from colorectalcarcinoma.
16
Background and objectives: The factors influencing the growth rate of colorectalcarcinoma have not been determined.